Skip to main content

Table 4 Association between CD147 plasma membrane expression, alone or co-expressed with MCT1, and the clinical-pathological parameters

From: Characterization of monocarboxylate transporters (MCTs) expression in soft tissue sarcomas: distinct prognostic impact of MCT1 sub-cellular localization

Clinical-pathological data CD147 CD147 + MCT1 CD147 + MCT4
n Positive (%) p Positive (%) p Positive (%) p
Age    0.498   0.583   0.308
 >51 48 23 (47.9)   21 (43.8)   18 (37.5)  
 ≤51 37 15 (40.5)   14 (37.8)   10 (27.0)  
Gender    0.577   0.523   0.680
 Female 33 16 (48.5)   15 (45.5)   10 (30.3)  
 Male 52 22 (42.3)   29 (38.5)   19 (34.6)  
Race    0.562   0.976   0.511
 Caucasian 63 27 (42.9)   26 (41.3)   22 (34.9)  
 Not Caucasian 22 11 (50.0)   9 (40.9)   6 (27.3)  
Local    0.936   0.751   0.432
 Lower extremities 63 28 (44.4)   25 (39.7)   19 (30.2)  
 Upper extremities 23 10 (43.5)   10 (43.5)   9 (39.1)  
Cell lineage    0.878   0.694   0.071
 Fibroblastic/myofibroblastic 28 13 (46.4)   12 (42.9)   12 (42.9)  
 Smooth muscle 17 6 (35.3)   6 (35.3)   5 (29.4)  
 Lipogenic 17 7 (41.2)   5 (29.4)   1 (5.9)  
 Peripheral nerve 7 3 (42.9)   3 (42.9)   2 (28.6)  
 Miscellaneous 17 9 (52.9)   9 (52.9)   8 (47.1)  
Cellular pleomorphism    0.083   0.071   0.002
 Absence of pleomorphic cells 54 20 (37.0)   18 (33.3)   11 (20.4)  
 Presence of pleomorphic cells 32 18 (56.2)   17 (53.1)   17 (53.1)  
Grade    0.076   0.016   0.026
 Low grade (I) 19 5 (26.3)   3 (15.8)   2 (10.5)  
 High grade (II e III) 67 33 (49.3)   32 (47.8)   26 (38.8)  
Disease progression    0.020   0.016   0.070
 No 25 6 (24.0)   5 (20.0)   4 (16.0)  
 Yes 56 29 (51.8)   27 (48.2)   21 (37.5)  
Disease recurrence    0.949   0.847   0.840
 Absent 48 21 (43.8)   19 (39.6)   15 (31.2)  
 Present 36 16 (44.4)   15 (41.7)   12 (33.3)  
Metastasis    0.295   0.090   0.593
 Absent 44 17 (38.6)   14 (31.8)   13 (29.5)  
 Present 40 20 (50.0)   20 (50.0)   14 (35.0)  
  1. Significant values are shown in bold.